Prof. Sanjay K. Srivastava

Texas Tech University Health Sciences Center, USA

Email: [email protected]

Qualifications

1991 Ph.D., ITRC/Kanpur University, India

1987 M.Sc., Lucknow University, India

1985 B.Sc., Lucknow University, India

Publications (selected)

1. Gaikwad, S. and Srivastava, S.K. Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy. Molecular Therapy, 32(9):3145-3162, 2024.
2. Gupta, N., Curcic, M. and Srivastava, S.K. Proguanil Suppresses Breast Tumor Growth In Vitro and In Vivo by Inducing Apoptosis via Mitochondrial Dysfunction. Cancers, 16(5), 2024.
3. Srivastava, S.K. and Kim, S.H. Special issue: Modulation of immune checkpoint proteins and their networks in cancer progression. Seminars in Cancer Biology, 93:1-2, 2023.
4. Nguyen, H.M., Gaikwad, S., Oladejo, M., Agrawal, M.Y., Srivastava, S.K. and Wood, L.M. Interferon stimulated gene 15 (ISG15) in cancer: An update. Cancer Letters, 556:216080, 2023.
5. Agrawal, M.Y., Gaikwad, S., Srivastava, S. and Srivastava, S.K. Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics. Cancers, 14(22), 2022.
6. Gaikwad, S., Agrawal, M.Y., Kaushik, I., Ramachandran, S. and Srivastava, S.K. Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy. Seminars in Cancer Biology, 86(Pt 3):137-150, 2022.
7. Kaushik, I., Ramachandran, S., Zabel, C., Gaikwad, S. and Srivastava, S.K. The evolutionary legacy of immune checkpoint inhibitors. Seminars in Cancer Biology, 86(Pt 2):491-498, 2022.
8. Kaushik, I. and Srivastava, S.K. GABA(A) receptor agonist suppresses pediatric medulloblastoma progression by inhibiting PKA-Gli1 signaling axis. Molecular Therapy, 30(7):2584-2602, 2022.
9. Gupta, N. and Srivastava, S.K. Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis. Pharmaceuticals, 14(6), 2021.
10. Gupta, N., Gaikwad, S., Kaushik, I., Wright, S.E., Markiewski, M.M. and Srivastava, S.K. Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells. International Journal of Molecular Sciences, 22(10), 2021.
11. Gaikwad, S. and Srivastava, S.K. Role of Phytochemicals in Perturbation of Redox Homeostasis in Cancer. Antioxidants, 10(1), 2021.
12. Butler, M., Prasad, S. and Srivastava, S.K. Targeting Glioblastoma Tumor Microenvironment. Advances in Experimental Medicine and Biology, 1296:1-9, 2020.
13. Kwan, A., Winder, N., Atkinson, E., Al-Janabi, H., Allen, R.J., Hughes, R., Moamin, M., Louie, R., Evans, D., Hutchinson, M., Capper, D., Cox, K., Handley, J., Wilshaw, A., Kim, T., Tazzyman, S.J., Srivastava, S., Ottewell, P., Vadakekolathu, J., Pockley, G., Lewis, C.E., Brown, J.E., Danson, S.J., Conner, J. and Muthana, M. Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors. Molecular Cancer Therapeutics, 20(3):589-601, 2021.
14. Ranjan, A., Kaushik, I. and Srivastava, S.K. Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy. Cells, 9(9), 2020.
15. Ramachandran, S. and Srivastava, S.K. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy. Molecular Therapy Oncolytics, 19:19-32, 2020.
16. Srivastava, S.K. Special issue: Drug repurposing for cancer therapy. Seminars in Cancer Biology, 68:1-2, 2021.
17. Kaushik, I., Ramachandran, S., Prasad, S. and Srivastava, S.K. Drug rechanneling: A novel paradigm for cancer treatment. Seminars in Cancer Biology, 68:279-290, 2021.
18. Srivastava, S., Zahra, F.T., Gupta, N., Tullar, P.E., Srivastava, S.K. and Mikelis, C.M. Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis. International Journal of Molecular Sciences, 21(3), 2020.
19. Prasad, S. and Srivastava, S.K. Oxidative Stress and Cancer: Chemopreventive and Therapeutic Role of Triphala. Antioxidants, 9(1), 2020.
20. Ghouse, S.M., Vadrevu, S.K., Manne, S., Reese, B., Patel, J., Patel, B., Silwal, A., Lodhi, N., Paterson, Y., Srivastava, S.K., Karbowniczek, M. and Markiewski, M.M. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis. Journal of Immunology, 204(4):990-1000, 2020.

Personal Details

WoS Researcher ID: AAE-7635-2020

https://loop.frontiersin.org/people/684757/overview

https://scholar.google.com/citations?user=WC8qQHMAAAAJ&hl=en&citsig=AFPfF8dz0S1R4aMz8diJxHdnTQ8Q

https://www.researchgate.net/profile/Sanjay-Srivastava-4

https://www.linkedin.com/in/sanjay-k-srivastava-m-s-ph-d-faaas-frsb-2518087/